2016
Exploring Explanations for the Female-Male Earnings Difference Among Registered Nurses in the United States.
Muench U, Busch SH, Sindelar J, Buerhaus PI. Exploring Explanations for the Female-Male Earnings Difference Among Registered Nurses in the United States. Nursing Economics 2016, 34: 214-23. PMID: 29975036.Peer-Reviewed Original Research
2015
Salary Differences Between Male and Female Registered Nurses in the United States
Muench U, Sindelar J, Busch SH, Buerhaus PI. Salary Differences Between Male and Female Registered Nurses in the United States. JAMA 2015, 313: 1265-1267. PMID: 25803350, DOI: 10.1001/jama.2015.1487.Peer-Reviewed Original Research
2012
Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample
Young-Wolff KC, Hyland AJ, Desai R, Sindelar J, Pilver CE, McKee SA. Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample. Drug And Alcohol Dependence 2012, 128: 214-221. PMID: 22999418, PMCID: PMC4052952, DOI: 10.1016/j.drugalcdep.2012.08.028.Peer-Reviewed Original ResearchConceptsAlcohol use disorderSmoke-free legislationSmoke-free policiesAUD remissionUse disordersLikelihood of AUDWave IIndoor public venuesLongitudinal U.S. sampleTobacco-related diseasesYounger age groupsNational Epidemiological SurveySmoke-free barsPublic health benefitsAUD onsetHigh comorbidityProtective effectCurrent drinkersTobacco useEpidemiological surveyAge groupsLogistic regressionRelated conditionsHeavy drinkingLower likelihood
2011
UNDERSTANDING HETEROGENEITY IN PRICE ELASTICITIES IN THE DEMAND FOR ALCOHOL FOR OLDER INDIVIDUALS
Ayyagari P, Deb P, Fletcher J, Gallo W, Sindelar JL. UNDERSTANDING HETEROGENEITY IN PRICE ELASTICITIES IN THE DEMAND FOR ALCOHOL FOR OLDER INDIVIDUALS. Health Economics 2011, 22: 89-105. PMID: 22162113, PMCID: PMC3641566, DOI: 10.1002/hec.1817.Peer-Reviewed Original ResearchConceptsPrice elasticityRetirement Study dataDeadweight lossHigher taxPrice responsivenessNegative externalitiesUnobserved heterogeneityPolicy implicationsFinancial resourcesExternalitiesPricesFinite mixture modelDisadvantaged groupsElasticityLatent groupsDemandTaxGreater responsivenessOlder IndividualsStudy dataHeterogeneityImplicationsResourcesThe effect of job loss on overweight and drinking
Deb P, Gallo WT, Ayyagari P, Fletcher JM, Sindelar JL. The effect of job loss on overweight and drinking. Journal Of Health Economics 2011, 30: 317-327. PMID: 21288586, PMCID: PMC3086369, DOI: 10.1016/j.jhealeco.2010.12.009.Peer-Reviewed Original Research
2009
Work expectations, realizations, and depression in older workers.
Falba TA, Sindelar JL, Gallo WT. Work expectations, realizations, and depression in older workers. The Journal Of Mental Health Policy And Economics 2009, 12: 175-86. PMID: 20195005, PMCID: PMC3434685.Peer-Reviewed Original ResearchThe Impact of Occupation on Self-Rated Health: Cross-Sectional and Longitudinal Evidence from the Health and Retirement Survey
Gueorguieva R, Sindelar JL, Falba TA, Fletcher JM, Keenan P, Wu R, Gallo WT. The Impact of Occupation on Self-Rated Health: Cross-Sectional and Longitudinal Evidence from the Health and Retirement Survey. The Journals Of Gerontology Series B 2009, 64B: 118-124. PMID: 19196689, PMCID: PMC2654983, DOI: 10.1093/geronb/gbn006.Peer-Reviewed Original ResearchConceptsSelf-reported healthOlder individualsSelf-reported health statusSignificant baseline differencesSelf-rated healthHealth habitsBaseline differencesOccupation-related differencesHealth statusHealth trajectoriesImpact of occupationKey covariatesStudy sampleSignificant differencesRetirement StudyHealthOccupational categoriesRetirement SurveyLongitudinal evidenceIndividual ageOccupational differencesIndividualsDifferences
2008
Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients
Jones ES, Moore BA, Sindelar JL, O’Connor P, Schottenfeld RS, Fiellin DA. Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug And Alcohol Dependence 2008, 99: 132-140. PMID: 18804923, PMCID: PMC2646001, DOI: 10.1016/j.drugalcdep.2008.07.013.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBuprenorphineCohort StudiesCost of IllnessCosts and Cost AnalysisData Interpretation, StatisticalFemaleHealth PersonnelHumansMaleMethadoneMiddle AgedNarcoticsOpioid-Related DisordersPhysicians' OfficesSocioeconomic FactorsSubstance Abuse DetectionSubstance Abuse Treatment CentersTreatment OutcomeYoung AdultConceptsOffice-based treatmentOpioid dependencePatient costsClinical contactMonthly medication costsOffice-based buprenorphineOffice-based methadoneMonths of treatmentAnalysis of treatmentTotal monthly costsChi-square testMonths of maintenanceStable patientsMedication costsPatientsMethadoneMonthly costBuprenorphineTreatmentMonthsStatistical comparisonCost estimatesClinic
2007
Willingness to pay for drug rehabilitation: Implications for cost recovery
Bishai D, Sindelar J, Ricketts EP, Huettner S, Cornelius L, Lloyd JJ, Havens JR, Latkin CA, Strathdee SA. Willingness to pay for drug rehabilitation: Implications for cost recovery. Journal Of Health Economics 2007, 27: 959-972. PMID: 18207264, PMCID: PMC2601723, DOI: 10.1016/j.jhealeco.2007.11.007.Peer-Reviewed Original ResearchSpousal Concordance in Health Behavior Change
Falba TA, Sindelar JL. Spousal Concordance in Health Behavior Change. Health Services Research 2007, 43: 96-116. PMID: 18211520, PMCID: PMC2323137, DOI: 10.1111/j.1475-6773.2007.00754.x.Peer-Reviewed Original ResearchConceptsHealth habitsHealth behaviorsPreventive medical careHealth behavior changeCholesterol screeningFlu shotPreventive servicesMedical careSpousal concordanceAnalytic sampleRetirement StudyHRS surveyBehavior changeRepresentative sampleSpousesHabitsSpouse behaviorDisease diagnosisIndividualsLongitudinal dataSmokingDiagnosisPersonsCareDirect Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs
McCarty D, Fuller BE, Arfken C, Miller M, Nunes EV, Edmundson E, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW. Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs. Psychiatric Services 2007, 58: 181-190. PMID: 17287373, PMCID: PMC2861362, DOI: 10.1176/ps.2007.58.2.181.Peer-Reviewed Original ResearchAdultAge FactorsAlcoholismAttitude of Health PersonnelBehavior TherapyClinical Trials as TopicCognitive Behavioral TherapyCultureData CollectionDiffusion of InnovationEducational StatusEthnicityEvidence-Based MedicineFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient Care TeamProfessional CompetenceProfessional-Patient RelationsPsychotropic DrugsSex FactorsSocioeconomic FactorsSubstance Abuse Treatment CentersSubstance-Related DisordersUnited StatesWhat do we get for our money? Cost‐effectiveness of adding contingency management
Sindelar J, Elbel B, Petry NM. What do we get for our money? Cost‐effectiveness of adding contingency management. Addiction 2007, 102: 309-316. PMID: 17222286, DOI: 10.1111/j.1360-0443.2006.01689.x.Peer-Reviewed Original Research
2006
Effectiveness of Switching Antipsychotic Medications
Essock SM, Covell NH, Davis SM, Stroup TS, Rosenheck RA, Lieberman JA. Effectiveness of Switching Antipsychotic Medications. American Journal Of Psychiatry 2006, 163: 2090-2095. PMID: 17151159, DOI: 10.1176/ajp.2006.163.12.2090.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntipsychotic AgentsBenzodiazepinesCross-Over StudiesDibenzothiazepinesDose-Response Relationship, DrugDouble-Blind MethodDrug Administration ScheduleHumansMiddle AgedOlanzapinePatient DropoutsPsychotherapyQuetiapine FumarateResearch DesignRisperidoneSchizophreniaSchizophrenic PsychologySelection BiasSurvival AnalysisTreatment OutcomeConceptsMedication changesDifferent antipsychoticsCause treatment discontinuationCurrent medication regimensClinical Antipsychotic TrialsPhase 1 analysisPhase 1 findingsBaseline medicationsSwitching medicationsTreatment discontinuationMedication regimensPrimary outcomeMedication effectivenessAntipsychotic medicationAntipsychotic TrialsMedicationsAntipsychoticsClinical situationsOlanzapinePatientsRisperidoneIntervention effectivenessDearth of informationDiscontinuationRandom assignmentCost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J. Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia. American Journal Of Psychiatry 2006, 163: 2080-2089. PMID: 17151158, DOI: 10.1176/ajp.2006.163.12.2080.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntipsychotic AgentsChronic DiseaseCost-Benefit AnalysisDrug CostsFollow-Up StudiesHealth Care CostsHumansLongitudinal StudiesMiddle AgedPatient DropoutsPerphenazinePsychiatric Status Rating ScalesQuality-Adjusted Life YearsResearch DesignSchizophreniaSchizophrenic PsychologyTreatment Outcome
2005
The impact of tobacco expenditure on household consumption patterns in rural China
Wang H, Sindelar JL, Busch SH. The impact of tobacco expenditure on household consumption patterns in rural China. Social Science & Medicine 2005, 62: 1414-1426. PMID: 16137812, DOI: 10.1016/j.socscimed.2005.07.032.Peer-Reviewed Original ResearchConceptsLow-income countriesTobacco spendingRural ChinaDurable goods consumptionHousehold expenditure patternsHuman capital investmentHousehold consumption patternsFractional logit modelBasic needsDistributional impactsTobacco expenditureExpenditure patternsGoods consumptionLogit modelCapital investmentFarming productivityFinancial securitySpendingHousehold surveyConsumption patternsExpenditureHouseholdsEstimation methodCountriesChinaThe effect of involuntary job loss on smoking intensity and relapse
Falba T, Teng H, Sindelar JL, Gallo WT. The effect of involuntary job loss on smoking intensity and relapse. Addiction 2005, 100: 1330-1339. PMID: 16128722, PMCID: PMC1351253, DOI: 10.1111/j.1360-0443.2005.01150.x.Peer-Reviewed Original ResearchConceptsCurrent smokersBaseline current smokersHistory of smokingWave 2Important health risk factorHealth risk factorsTimes greater oddsFormer smokersOlder smokersPrimary outcomeMore cigarettesSmoking intensityRisk factorsCigarette consumptionGreater oddsRelapseSmokersSmoking quantityOlder AmericansSmokingRetirement StudyWave 1Significant changesInvoluntary job lossFinancial hardshipIf smoking increases absences, does quitting reduce them?
Sindelar JL, Duchovny N, Falba TA, Busch SH. If smoking increases absences, does quitting reduce them? Tobacco Control 2005, 14: 99. PMID: 15791019, PMCID: PMC1747999, DOI: 10.1136/tc.2003.005884.Peer-Reviewed Original ResearchThe role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment
Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal Of Substance Use And Addiction Treatment 2005, 28: 189-196. PMID: 15780549, DOI: 10.1016/j.jsat.2004.12.005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmbulatory CareComorbidityConnecticutCross-Sectional StudiesDepressionFemaleFinancing, GovernmentHumansMaleMiddle AgedMotivationPatient CompliancePatient DischargePublic AssistanceRegression AnalysisSecondary PreventionSocioeconomic FactorsSubstance Abuse DetectionSubstance-Related DisordersTreatment OutcomeConceptsLength of staySubstance abuse treatment outcomesOutpatient substance abuse treatmentSubstance abuse treatmentDepressive symptomsInsurance statusTreatment outcomesAbstinence statusDepression symptomsDrug useDrug abstinenceAbuse treatmentReal-world clinical settingHigher depressive symptom scoresOutpatient substance abuse treatment programsDepressive symptom scoresSubstance abuse treatment programsSymptom scoresTreatment characteristicsPrimary drugDecreased likelihoodReferral sourceClinical settingSymptomsTreatment program
2004
Value to smokers of improved cessation products: Evidence from a willingness-to-pay survey
Busch S, Falba T, Duchovny N, Jofre-Bonet M, O'Malley S, Sindelar J. Value to smokers of improved cessation products: Evidence from a willingness-to-pay survey. Nicotine & Tobacco Research 2004, 6: 631-639. PMID: 15370159, DOI: 10.1080/14622200410001727885.Peer-Reviewed Original ResearchConceptsSmoking cessation productsSmoking cessationCessation productsCessation treatmentEffective smoking cessation treatmentsWeight gainTobacco cessation treatmentSmoking cessation treatmentPresent studyClinical trialsEffective treatmentBaseline surveyCessationTreatmentNew HavenMedicationsSmokersTrials
2003
Reduction of quantity smoked predicts future cessation among older smokers
Falba T, Jofre‐Bonet M, Busch S, Duchovny N, Sindelar J. Reduction of quantity smoked predicts future cessation among older smokers. Addiction 2003, 99: 93-102. PMID: 14678067, DOI: 10.1111/j.1360-0443.2004.00574.x.Peer-Reviewed Original ResearchConceptsQuantity of cigarettesSmoking quantityLikelihood of cessationChronic health problemsWarrants further studyHarm reduction strategiesOlder smokersSecondary outcomesPrimary outcomeSmoking cessationFirst followSmoking levelsFuture cessationPsychiatric problemsHealth problemsAlcohol useBeneficial effectsMarital statusCessationOlder AmericansSmokersFurther studiesModerate reductionRetirement StudyCigarettes